VKTX | Viking Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	50.40 - 53.04
52 Week Range	11.21 - 99.41
Beta	0.89
Implied Volatility	83.52%
IV Rank	19.48%
Day's Volume	3,479,409
Average Volume	4,123,733
Shares Outstanding	111,436,000
Market Cap	5,742,297,080
Sector	Healthcare
Industry	Biotechnology
IPO Date	2015-04-28

Valuation
Profitability
Growth
Health
P/E Ratio	-54.82
Forward P/E Ratio	N/A
EPS	-0.94
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	30
Country	USA
Website	VKTX

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

VKTX's peers: ACAD, AGEN, AKRO, ALT, ATNM, AUPH, AVXL, AXSM, BCRX, BLUE, BTAI, CPRX, ETNB, EXEL, GALT, GERN, IBRX, IONS, MDGL, MRNS, PBYI, PTCT, SAVA, SRPT, TGTX, VIR, ICPT, TERN, RETA, HEPA, IMGN, MCRB, DAWN, XFOR, INZY, ABOS, MREO, AVRO, CWBR, OCEA, ENVB, ELEV, VRNA, VRTX, VSTM

*Chart delayed

Analyzing fundamentals for VKTX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see VKTX Fundamentals page.

Watching at VKTX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on VKTX Technicals page.